Stress Biomarkers Leading to Professional Burnout Among People Involved in a Mobile Intensive Care Unit During the COVID-19 Pandemic

NCT04365335 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2021-03-09

No results posted yet for this study

Summary

This study is aiming at investigating whether professional burnout in people involved in the mobile intensive care unit (in French: Element Mobile de Réanimation, EMR) in Mulhouse (France) can be predicted upstream by a low mindfulness level (as a protective factor) or by a dysregulation of stress pathways with a high level of perceived stress towards an emotional event (psychological index of allostatic load), i.e. an early and silent dysfunctional physiological response (measured by the electrophysiological and biological measurements of allostasis load and parasympathetic brake).

It is part of a global approach aiming at identifying levers to prevent the allostatic load of occupational stress related to large-scale health crises.

Conditions

  • Occupational Stress

Interventions

BEHAVIORAL

Assessment of work-related stress

Assessment of burnout, mindfulness, interoceptive awareness, anxiety, post-traumatic stress disorder, coping flexibility and sleep through questionnaires.

BIOLOGICAL

Saliva sample collection

Saliva sample is collected before and after emotional stimulation in order to measure resting-state allostatic load biomarkers: DHEA, cortisol and chromogranine A levels

OTHER

Cardiac and electrodermal recordings

Electrocardiogram and electrodermal activity (tonic and phasic) is collected at rest and after emotional stimulation.

BEHAVIORAL

Assessment of behavioral response to emotional stimulation

Emotional stimulation involves asking the participants to remember a recent event related to the COVID-19 crisis that has been emotionally difficult for them. Perceived stress, situational awareness and emotions is assessed after emotional stimulation through questionnaires.

Sponsors & Collaborators

  • Institut de Recherche Biomedicale des Armees

    collaborator OTHER_GOV
  • Direction Centrale du Service de Santé des Armées

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-04-25
Primary Completion
2020-06-12
Completion
2020-06-12

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04365335 on ClinicalTrials.gov